Difference between revisions of "Human Brucellosis"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
{{unfinished}} | {{unfinished}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Young, E. J. (1995) '''An Overview of Human Brucellosis''' ''Clinical Infectious Diseases 21, No. 2 pp. 283-289'' | Young, E. J. (1995) '''An Overview of Human Brucellosis''' ''Clinical Infectious Diseases 21, No. 2 pp. 283-289'' | ||
| Line 20: | Line 14: | ||
| − | [[Category:To_Do_- | + | [[Category:To_Do_-_Clinical]] |
Revision as of 08:45, 25 July 2010
 |
This article is still under construction. |
Young, E. J. (1995) An Overview of Human Brucellosis Clinical Infectious Diseases 21, No. 2 pp. 283-289
- Transmission via contact with secretions from infected animals
- Routes of infection: skin abrasions, inhalation, ingestion
- Unpasteurised milk source of infection
- Undulant fever - fluctuating pyrexia, malaise, fatigue, muscle and joint pains, osteomyelitis
- Can become chronic
- B melitensis and B. suis cause most severe infections
- Antimicrobials